Page last updated: 2024-08-25

beta-amyrin and Insulin Sensitivity

beta-amyrin has been researched along with Insulin Sensitivity in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Alves, APNN; Carvalho, AA; Chaves, MH; Fonseca, SGC; Lima, RP; Nunes, PIG; Oliveira, FTB; Rao, VS; Santos, FA; Silva, RAC; Viana, AFSC; Viana, DA	1
Bishayee, A; Deshmukh, RR; Kumar, P; Kumar, S; Sharma, H	1
Dinda, AK; Gupta, YK; Maulik, SK; Prabhakar, P; Reeta, KH	1

Reviews

1 review(s) available for beta-amyrin and Insulin Sensitivity

Article	Year
Pentacyclic triterpenes: New tools to fight metabolic syndrome. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2018, Nov-15, Volume: 50 Topics: Animals; Heart; Humans; Insulin Resistance; Liver; Metabolic Syndrome; Muscle, Skeletal; Oleanolic Acid; Oxidative Stress; Pentacyclic Triterpenes; Triterpenes; Ursolic Acid	2018

Other Studies

2 other study(ies) available for beta-amyrin and Insulin Sensitivity

Article	Year
α,β-Amyrin prevents steatosis and insulin resistance in a high-fat diet-induced mouse model of NAFLD via the AMPK-mTORC1-SREBP1 signaling mechanism. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2021, Volume: 54, Issue:10 Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Insulin Resistance; Liver; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oleanolic Acid; Sterol Regulatory Element Binding Protein 1	2021
α-Amyrin attenuates high fructose diet-induced metabolic syndrome in rats. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2017, Volume: 42, Issue:1 Topics: Administration, Oral; Animals; Antihypertensive Agents; Antioxidants; Diet, Carbohydrate Loading; Dose-Response Relationship, Drug; Fructose; Gene Expression Regulation; Hyperglycemia; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Liver; Male; Metabolic Syndrome; Oleanolic Acid; Oxidative Stress; PPAR alpha; Random Allocation; Rats, Wistar	2017

Article

Year

α,β-Amyrin prevents steatosis and insulin resistance in a high-fat diet-induced mouse model of NAFLD via the AMPK-mTORC1-SREBP1 signaling mechanism.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2021, Volume: 54, Issue:10

Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Insulin Resistance; Liver; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oleanolic Acid; Sterol Regulatory Element Binding Protein 1

2021

α-Amyrin attenuates high fructose diet-induced metabolic syndrome in rats.

Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme, 2017, Volume: 42, Issue:1

Topics: Administration, Oral; Animals; Antihypertensive Agents; Antioxidants; Diet, Carbohydrate Loading; Dose-Response Relationship, Drug; Fructose; Gene Expression Regulation; Hyperglycemia; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Liver; Male; Metabolic Syndrome; Oleanolic Acid; Oxidative Stress; PPAR alpha; Random Allocation; Rats, Wistar

2017